Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Axyntis, PMC vie to buy Isochem

by Rick Mullin
October 30, 2017 | A version of this story appeared in Volume 95, Issue 43

Axyntis—a French pharmaceutical chemical company—and New Jersey-based PMC Group are vying to acquire Isochem, the French contract manufacturer of pharmaceutical chemicals spun out from state-owned SNPE in 2010. The firm is currently owned by Aurelius, a German industrial holding company. Isochem has four manufacturing sites in France. Axyntis operates seven manufacturing and research sites in France. PMC manufactures performance additives for drugs and other markets at plants in the U.S., Europe, and Asia. Isochem filed for receivership with the French commercial court earlier this year when Gilead Sciences canceled an order for a drug intermediate.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.